Clinical Research Directory
Browse clinical research sites, groups, and studies.
Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors
Sponsor: Children's Hospital Medical Center, Cincinnati
Summary
The purpose of this pilot study is to investigate the safety and preliminarily assess efficacy of early intervention with zoledronate in high risk pediatric hematopoietic stem cell transplantation (HSCT) patients to prevent the development of bone disease and fractures and reduce potential pain and suffering.
Official title: Early Intervention With Zoledronate to Safely Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors
Key Details
Gender
All
Age Range
5 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-02
Completion Date
2028-11
Last Updated
2026-01-29
Healthy Volunteers
No
Conditions
Interventions
Zoledronate
Zoledronate is in the class of drugs entitled bisphosphonates which act to inhibit bone resorption by inhibiting osteoclast activity therefore reducing bone turnover.
Locations (1)
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States